(Q54322936)

English

Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.

scientific article published on 21 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia. (English)

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

1 reference

based on heuristic

inferred from title

author name string

Yi-Torng Tee

1

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Po-Hui Wang

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Hsiu-Ting Tsai

3

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Long-Yau Lin

4

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Hung-Ting Lin

5

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Shun-Fa Yang

6

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Yi-Hsien Hsieh

7

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Tsung-Ho Ying

8

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

publication date

21 February 2012

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Journal of Surgical Oncology

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

106

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

204-208

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Diagnosis and management of cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Modulators of the urokinase-type plasminogen activation system for cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

The role of plasminogen-plasmin system in cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

The urokinase plasminogen activator system: role in malignancy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23072

21 January 2018

Identifiers

10.1002/JSO.23072

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/22354580

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54322936&oldid=1517925283"